|
Nine Months Ended
|
||||||||
|
July 31,
2022
|
August 1,
2021
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net income
|
$
|
123,978
|
$
|
50,185
|
||||
|
Adjustments to reconcile net income to net cash
|
||||||||
|
provided by operating activities:
|
||||||||
|
Depreciation and amortization
|
61,210
|
69,305
|
||||||
|
Share-based compensation
|
4,623
|
4,034
|
||||||
|
Changes in operating assets, liabilities and other
|
6,110
|
(10,428
|
)
|
|||||
|
Net cash provided by operating activities
|
195,921
|
113,096
|
||||||
|
Cash flows from investing activities:
|
||||||||
|
Purchases of property, plant and equipment
|
(46,337
|
)
|
(92,301
|
)
|
||||
|
Government incentives
|
1,394
|
5,775
|
||||||
|
Other
|
(179
|
)
|
(170
|
)
|
||||
|
Net cash used in investing activities
|
(45,122
|
)
|
(86,696
|
)
|
||||
|
Cash flows from financing activities:
|
||||||||
|
Repayments of debt
|
(51,917
|
)
|
(13,311
|
)
|
||||
|
Purchases of treasury stock
|
(2,522
|
)
|
(35,750
|
)
|
||||
|
Contributions from noncontrolling interest
|
24,995
|
-
|
||||||
|
Proceeds from share-based arrangements
|
5,505
|
2,251
|
||||||
|
Proceeds from long-term debt
|
-
|
20,858
|
||||||
|
Net settlements of restricted stock awards
|
(1,463
|
)
|
(403
|
)
|
||||
|
Net cash used in financing activities
|
(25,402
|
)
|
(26,355
|
)
|
||||
|
Effects of exchange rate changes on cash, cash equivalents, and restricted cash
|
(21,308
|
)
|
4,602
|
|||||
|
Net increase in cash, cash equivalents, and restricted cash
|
104,089
|
4,647
|
||||||
|
Cash, cash equivalents, and restricted cash, beginning of period
|
279,680
|
281,602
|
||||||
|
Cash, cash equivalents, and restricted cash, end of period
|
$
|
383,769
|
$
|
286,249
|
||||